August 31, 2016
Recommended Topic Related To:

Clindamycin Phosphate Topical Solution

"The U.S. Food and Drug Administration today approved Differin Gel 0.1% (adapalene), a once-daily topical gel for the over-the-counter (OTC) treatment of acne. Differin Gel 0.1% is approved for use in people 12 years of age and older.



Clindamycin Phosphate Topical Solution

Clindamycin Phosphate Topical Solution Side Effects Center

Medical Editor: John P. Cunha, DO, FACOEP

Last reviewed on RxList 5/22/2015

Clindamycin Phosphate Topical Solution is a topical (for the skin) antibiotic used to treat acne vulgaris. Clindamycin Phosphate Topical Solution is available in generic form. Common side effects of Clindamycin Phosphate Topical Solution include burning, itching, dry skin, redness, oily skin, or peeling.

Apply a thin film of Clindamycin Phosphate Topical Solution or use a Clindamycin Phosphate Topical Solution pledget (pad) twice daily to affected area. More than one pledget may be used if needed. Discard any used pledgets and wash hands thoroughly after application. Clindamycin Phosphate Topical Solution may interact with other neuromuscular blocking agents. There may be other drugs that can interact with Clindamycin Phosphate Topical Solution. Tell your doctor all prescription and over-the-counter medications you are taking. Clindamycin Phosphate Topical Solution should be used during pregnancy only if prescribed. It is not known if the topical form of this medication passes in breast milk. Oral forms of clindamycin pass into breast milk. Consult your doctor before breast-feeding.

Our Clindamycin Phosphate Topical Solution Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Clindamycin Phosphate Topical Solution FDA Prescribing Information: Side Effects
(Adverse Reactions)


In 18 clinical studies of various formulations of topical Clindamycin Phosphate using placebo vehicle and/or active comparator drugs as controls, patients experienced a number of treatment emergent adverse dermatologic events [see table below].

Number of Patients Reporting Events

Treatment Emergent
Adverse Event
n=553 (%)
n=148 (%)
n=160 (%)
Burning 62 (11) 15 (10) 17 (11)
Itching 36 ( 7 ) 15 (10) 17 (11)
Burning/Itching 60 (11) # (-- ) # (-- )
Dryness 105 (19) 34 (23) 29 (18)
Erythema 86 (16) 10 ( 7 ) 22 (14)
Oiliness/Oily Skin 8 ( 1 ) 26 (18) 12*(10)
Peeling 61 (11) # (-- ) 11 ( 7 )
# not recorded
* of 126 subjects

Orally and parenterally administered clindamycin has been associated with severe colitis which may end fatally.

Cases of diarrhea, bloody diarrhea and colitis (including pseudomembranous colitis) have been reported as adverse reactions in patients treated with oral and parenteral formulations of clindamycin and rarely with topical clindamycin (see WARNINGS).

Abdominal pain and gastrointestinal disturbances as well as gram-negative folliculitis have also been reported in association with the use of topical formulations of clindamycin.

Read the entire FDA prescribing information for Clindamycin Phosphate Topical Solution (Clindamycin Phosphate Topical Solution)

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.

Health Resources
Use Pill Finder Find it Now See Interactions

Pill Identifier on RxList

  • quick, easy,
    pill identification

Find a Local Pharmacy

  • including 24 hour, pharmacies

Interaction Checker

  • Check potential drug interactions
Search the Medical Dictionary for Health Definitions & Medical Abbreviations